NCT06958627
- Conditions
- HER2 Positive Breast Cancer, Pyrotinib Treatment
- Locations
-
- Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
Clinical trial condition
HER2 Positive Breast Cancer
Explore clinical trials studying HER2 Positive Breast Cancer. Study availability and eligibility vary by location and protocol.
16 public trials
2 recruiting studies
HER2 Positive Breast Cancer trial results
NCT01785420
- Conditions
- Breast Diseases, Breast Neoplasms, Carcinoma Breast Stage I, +5 more
- Locations
-
- Tata Memorial Centre Mumbai, India
NCT06868017
- Conditions
- HER2 Positive Breast Cancer
- Locations
-
Not specified
Active, not recruiting
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer
NCT05132582
- Conditions
- Breast Diseases, Breast Neoplasms, HER2 Positive Breast Cancer, +4 more
- Locations
-
- Mayo Clinic Hospital Phoenix, Arizona, United States
- Mayo Clinic Scottsdale, Arizona, United States
- Central Arkansas Radiation Therapy Institute Inc d.b.a CARTI Little Rock, Arkansas, United States
- UCLA Hematology/Oncology - Beverly Hills Beverly Hills, California, United States
Active, not recruiting
Three Antidiarrheal Strategies in HER2+/HR+ Early Breast Cancer Patients Treated With Extended Adjuvant Neratinib
NCT05252988
- Conditions
- Breast Diseases, Breast Neoplasms, Early-Stage Breast Cancer, +6 more
- Locations
-
- Hospital General Universitario de Elche Elche, Alicante, Spain
- Hospital Costa del Sol Málaga, Andalusia, Spain
- Hospital Clínico Universitario Lozano Blesa Zaragoza, Aragon, Spain
- Institut Català d'Oncología (ICO) L'Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain
NCT02705859
- Conditions
- HER2 Positive Breast Cancer
- Locations
-
- Cancer Trials Ireland Investigative Site Cork, Ireland
- Cancer Trials Ireland Investigative Site Dublin, Ireland
- Cancer Trials Ireland Investigative Site Galway, Ireland
NCT04539938
- Conditions
- Breast Diseases, Breast Neoplasms, HER2 Positive Breast Cancer, +4 more
- Locations
-
- University Of Alabama at Birmingham Birmingham, Alabama, United States
- University of Alabama at Birmingham, IDS Pharmacy Birmingham, Alabama, United States
- University Of Alabama at Birmingham Birmingham, Alabama, United States
- Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
NCT01840306
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
- Locations
-
- Bon Secours Hospital Cork, Ireland
- Cork University Hospital Cork, Ireland
- Letterkenny General Hospital Donegal, Ireland
- Our Lady of Lourdes Hospital Drogheda, Ireland
NCT03013504
- Conditions
- Breast Diseases, Breast Neoplasms, HER2 Positive Breast Cancer, +4 more
- Locations
-
- Minsk Clinical Oncological Dispensary Minsk, Belarus
- Complex Oncology Center Plovdiv, Bulgaria
- East Tallinn Central Hospital Tallinn, Estonia
- Centre René Huguenin (Institut Curie) Saint-Cloud, France
NCT02476539
- Conditions
- HER2 Positive Breast Cancer
- Locations
-
- Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China